新冠肺炎疫苗:研发创新与全球可及难题  

COVID-19 Vaccine:Innovation Development and Problem in Global Access

作　　者：大卫·罗宾逊 史聪一(译) David K Robinson

机构地区：[1]不详

出　　处：《国际人才交流》2021年第10期18-21,共4页International Talent

摘　　要：如今,全球正面临巨大的挑战,如何应对新冠肺炎疫情已经成为各国重要任务。《华盛顿邮报》指出,新冠肺炎疫苗的研发花费了12-18个月,这是破世界纪录的研究速度。之前美国研制疫苗的最快时间是4年(根据1967年数据,腮腺炎疫苗研制需要4年),而艾滋病疫苗的研制可能至少需要36年。Currently,the world is facing significant challenges,and how to deal with COVID-19 Pandemic has become an essential task for all countries.As the Washington Post indicated,the COVID-19 vaccines were developed within 12 to 18 months,which would be a world record.Previously,the fastest time to create a vaccine in the United States was in four years(mumps vaccine,from scientific concept to approval in 1967),while an HIV vaccine quest could take 36 years and continuing.

关 键 词：《华盛顿邮报》 艾滋病疫苗 肺炎疫苗 研发创新 世界纪录 腮腺炎疫苗 疫情 如何应对 

分 类 号：S85[农业科学—兽医学]